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Iron regulatory protein 2 (IRP2) binds to iron-responsive elements (IREs) to regulate the translation and stability of mRNAs encoding several proteins
involved in mammalian iron homeostasis. Increases in cellular iron stimulate the polyubiquitylation and proteasomal degradation of IRP2. One study has
suggested that haem-oxidized IRP2 ubiquitin ligase-1 (HOIL-1) binds to a unique 73-amino acid (aa) domain in IRP2 in an iron-dependent manner to
regulate IRP2 polyubiquitylation and degradation. Other studies have questioned the role of the 73-aa domain in iron-dependent IRP2 degradation. We
investigated the potential role of HOIL-1 in the iron-mediated degradation of IRP2 in human embryonic kidney 293 (HEK293) cells. We found that
transiently expressed HOIL-1 and IRP2 interact via the 73-aa domain, but this interaction is not iron-dependent, nor does it enhance the rate of IRP2
degradation by iron. In addition, stable expression of HOIL-1 does not alter the iron-dependent degradation or RNA-binding activity of endogenous IRP2.
Reduction of endogenous HOIL-1 by siRNA has no affect on the iron-mediated degradation of endogenous IRP2. These data demonstrate that HOIL-1 is
not required for iron-dependent degradation of IRP2 in HEK293 cells, and suggest that a HOIL-1 independent mechanism is used for IRP2 degradation in
most cell types.
© 2007 Elsevier B.V. All rights reserved.Keywords: Iron; IRP2; HOIL-1; Ubiquitylation; Degradation; HEK2931. Introduction
Iron regulatory proteins 1 and 2 (IRP1 and IRP2) are cytosolic
RNA-binding proteins that regulate the expression of proteins
required for iron homeostasis, such as ferritin and transferrin
receptor-1 (TfR-1) [1–3]. When cellular iron content is low, IRPs
bind to iron-responsive elements (IREs) located in the 5′- or 3′-
untranslated region of ferritin and TfR-1 mRNAs, respectively.
These interactions result in decreased ferritin translation and
increased TfR-1 mRNA stability leading to increased intracellular
iron levels. As cellular iron content increases, IRP2 IRE-binding is
reduced due to protein degradation by the ubiquitin–proteasome
pathway [4–6]. In contrast to IRP2, increased cellular iron results
in the formation of a [4Fe–4S] cluster in IRP1 converting it into a
cytosolic aconitase while simultaneously reducing IRE-binding
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iron uptake thereby preventing iron toxicity.
Several lines of Irp1 and Irp2 knock-out mice have been
generated. Although no overt phenotype has been reported for
Irp1−/− mice, these animals show altered regulation of ferritin and
TfR-1 in liver, kidney, and brown fat [7,8]. Irp2−/−mice also show
altered ferritin and TfR-1 regulation as well as a mild neuro-
degeneration and microcytic anemia [7,9–12]. These phenotypes
are exacerbated in Irp1+/− Irp2−/− mice [11,13] while Irp1−/−
Irp2−/− mice do not survive past the blastocyst stage [14]. These
studies demonstrate the importance of the IRPs in regulating iron
homeostasis, and that dysregulation of the IRP/IRE regulatory
system has deleterious consequences.
Since the discovery of IRP2, its regulation by iron-mediated
degradation has remained controversial. Several amino acids
(C137, C168, C174, C178, C201, and H204) located within a
unique 73-amino acid (aa) region of IRP2 have been suggested to
be important for its iron/heme-dependent degradation [4,15–17].
To identify proteins involved in IRP2 degradation,Yamanaka et al.
performed a yeast two-hybrid screen using the 73-aa region of
IRP2 as bait, and isolated a clone that contained both an ubiquitin-
Fig. 1. FLAG-HOIL-1 interacts with full-length IRP2-Myc in HEK293 cells.
HEK293 cells were cotransfected with IRP2-Myc (IRP2) or IRP2Δ73-Myc (Δ73)
along with either empty vector (EV) or FLAG-HOIL-1 (HOIL-1). (A) 20 μg of
whole cell lysate was immunoblotted and probed simultaneously with c-Myc,
FLAG and actin antibodies to confirm expression of the cotransfected constructs.
Individual panels are from the same immunoblot but reordered for clarity.
(B) 500μg ofwhole cell lysatewas used to immunoprecipitate FLAG-HOIL-1with
FLAG antibody. Coimmunoprecipitation of IRP2-Myc or IRP2Δ73-Myc was
detected by immunoblotting using c-Myc antibody (upper panel). FLAG-HOIL-1
immunoprecipitation was confirmed using FLAG-HRP antibody (lower panel).
(C) 500 μg of whole cell lysate was used to immunoprecipitate IRP2-Myc or
IRP2Δ73-Myc using c-Myc antibody. Coimmunoprecipitation of FLAG-HOIL-1
was detected by immunoblotting using FLAG-HRP antibody (upper panel). IRP2-
Myc or IRP2Δ73-Myc immunoprecipitation was confirmed using c-Myc antibody
(lower panel). ⁎ indicates non-specific bands.
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was designated haem-oxidized IRP2 ubiquitin ligase-1 (HOIL-1)
[19]. Using African green-monkey COS-1 cells or rhabdomyo-
sarcoma RD4 cells, HOIL-1 was shown to interact with IRP2 in
iron- or hemin-treated cells but not in cells treated with an iron
chelator [19]. In vitro ubiquitylation assays showed increased
IRP2-ubiquitin conjugation in the presence of HOIL-1 suggesting
that HOIL-1 functioned as an E3 ubiquitin ligase [18,19]. Steady-
state levels of transiently expressed IRP2 were shown to be de-
creased in human embryonic kidney (HEK293) cells with the
coexpression of HOIL-1 [19] however the rate of IRP2 degra-
dation with or without HOIL-1 was not reported. The authors
concluded that HOIL-1 interacted specifically with the 73-aa do-
main of IRP2 in an iron-dependentmanner, and that this interaction
promoted IRP2 polyubiquitylation and proteasomal degradation.
In contrast to the report of Yamanaka et al. [19], studies have
shown that mutation of the five conserved cysteines or removal of
the entire 73-aa region (including all five cysteines andH204) does
not prevent the iron-dependent degradation of IRP2 in HEK293
and human lung cancer H1299 cells [6,20,21]. These conflicting
studies prompted us to determine if HOIL-1 has a role in regulating
IRP2 degradation and/or RNA-binding activity in HEK293 cells.
2. Materials and methods
2.1. Plasmids
The HOIL-1 (XAP3) cDNA (obtained from Dr. Ed Sato, University of South
Florida) was cloned into pCMV2c (Stratagene) at the XhoI site [22]. The N-
terminal FLAG-HOIL-1 construct was subcloned from pCMV2c into pcDNA5/
FRT/TO (Invitrogen) using KpnI and NotI and the orientation was reversed
using PmeI. Wild type rat IRP2 and human IRP2Δ73 (IRP2 with a deletion of
amino acids 137–209) cDNA containing a C-terminal 5xMyc-tag were cloned
into pcDNA3 (Invitrogen) at the NheI and XbaI sites.
2.2. Cell culture and transfection
All cell culture reagents were obtained from Invitrogen. HEK293T and COS-1
cells were cultured in complete Dulbecco's Modified Eagles complete medium
containing 9% heat-inactivated fetal bovine serum, 100 μg/ml penicillin, and 100 μg/
ml streptomycin at 37 °C in ambient air with 5% CO2. Flp-In™ TREx™-293 cells
were cultured in complete medium supplemented with 15 μg/ml blasticidin and
100μg/ml Zeocin™. HEK293Tor COS-1 cells were transiently transfected for 5 h in
OPTI-MEM using LipofectAMINE 2000 with a total of 4 or 5 μg of DNA, res-
pectively. FLAG-HOIL-1 stable cell lines were generated following the manufac-
turers' guidelines (Invitrogen) using the Flp-In™ TREx™ system, and cultured in
medium supplemented with 100 μg/ml hygromycin and 15 μg/ml blasticidin. Stable
FLAG-HOIL-1 expressionwas inducedwith 1 μg/ml tetracycline overnight (Sigma).
Cells were treated with 100 μg/ml ferric ammonium citrate (FAC), 100 μM des-
ferrioxamine mesylate (DFO) (Sigma), 20 μM hemin (Sigma), and 10 μMMG132
(Z-Leu–Leu–Leu-al) (Sigma) for the times indicated. Cells were harvested in Triton
Buffer (50 mMTris–HCl (pH 8.0), 150 mMNaCl, 1% Triton X-100, and Cocktail
Protease Inhibitors (Roche)) and lysateswere cleared by centrifugation at 12,000×g
for 15 min prior to immunoprecipitation or immunoblotting.
2.3. Immunoprecipitation and immunoblot analysis
Preparation of protein extracts and coprecipitation were carried out according to
Yamanaka et al. [19]. Protein extractswere immunoprecipitated inTritonBufferwith
12 μg FLAGM2 mAb (Sigma), 5 μg c-Myc (9E10) mAb (Covance), or IRP2 pAb
[23] for 1.5 h at 4 °C. Protein-G (FLAGand c-Myc immunoprecipitation) or Protein-
A (IRP2 immunoprecipitation) agarose (Invitrogen)was added for 1 h at 4 °C. Beads
were washed three times with Triton Buffer and one time with 20 mM Tris–HCl(pH 7.5). For immunoblotting of whole cell lysates and immunoprecipitations,
proteins were boiled in SDS-loading buffer and then loaded on an 8% SDS-PAGE.
Proteins were transferred to Hybond-ECL nitrocellulose membrane (Amersham)
and probed or re-probed with the following antibodies: c-Myc (9E10) mAb
(Covance), ferritin pAb (Sigma), FLAG M2 mAb (Sigma), FLAG M2-peroxidase
conjugated mAb (Sigma), actin mAb (Calbiochem), HOIL-1 (2E2) mAb (obtained
from Dr. Kazuhiro Iwai, Osaka City University) or rabbit anti-IRP2 antibody [23].
Horseradish peroxidase-conjugated secondary antibodies were bound and proteins
visualized using Western Lighting Chemiluminescence Reagent Plus (PerkinElmer
Life Sciences). If required, membranes were stripped using Stripping Buffer
(62.5 mM Tris–HCl (pH 6.8), 100 mM β-mercaptoethanol, and 2% SDS).
2.4. Protein degradation assays
Radiolabeling for degradation experiments was performed by incubating
transfected cells in methionine/cysteine (met/cys) free medium for 30 min prior to
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ceuticals). For transient IRP2-Myc degradation experiments, transfected cells
were 35S-Met/Cys labeled for 30 min and then washed three times followed by
incubation in completemedium (3%FBS)with or without 100 μg/ml FAC prior to
harvesting at the times indicated and immunoprecipitation using IRP2 antibody.
For endogenous IRP2 degradation experiments, Flp-In™ TREx™-293 and cells
stably expressing FLAG-HOIL-1 were induced with 1 μg/ml tetracycline
overnight, and then 35S-Met/Cys labeled for 1 h and chased in complete medium
(3%FBS) supplementedwith 1μg/ml tetracycline with orwithout 100μg/ml FAC
or 100 μM DFO. Unlabelled transiently transfected and tetracycline-induced
untransfected (control) and stable FLAG-HOIL-1 cells were also harvested at the
end of the time course for immunoblotting. Immunoprecipitated proteins were
separated by 8% SDS-PAGE or by 4–12% Bis-Tris NuPAGE (Invitrogen) and
transferred to nitrocellulose membrane for autoradiography or PhosphorImager
(Molecular Dynamics, Inc.) exposure. Band quantification was performed using a
local average background correction with ImageQuaNT 5.0 software (Molecular
Dynamics, Inc.).
2.5. RNA-electrophoretic mobility shift assay (EMSA)
Untransfected (control) or stable FLAG-HOIL-1 cells were induced
overnight with 1 μg/ml tetracycline in complete medium supplemented with
100 μg/ml FAC or 100 μM DFO. Cells were harvested and 12 μg whole cell
lysates were used for IRE-binding analysis as described previously [24] in the
presence or absence of 0.5% β-mercaptoethanol. IRP2 antibody was used for
supershift analysis.Fig. 2. The interaction of FLAG-HOIL-1 and IRP2-Myc is not iron-dependent. HEK293
FLAG-HOIL-1 (HOIL-1). Transfected cells were treated for 18 hwith DFO, themedium
treatment (C) or treatment with 100 μg/ml FAC (F), 20 μM hemin (H), or 100 μM DF
Immunoblotting and (B and D) immunoprecipitation were performed as described in Fi2.6. HOIL-1 siRNA
HEK293T cells (3×105 cells) were plated onto a 35-mm dish in complete
medium1day prior to transfection. The cellswere transfected using 100 nMHOIL-1
siRNA (DharmaconM-006932-01) with 5 μl DharmaFECT 1 for 24 h in antibiotic-
freemedium.Cells were then grown in completemedium for an additional 48 h prior
to treatment with 100 μg/ml FAC or 100 μMDFO for 8 h. Cells were harvested for
immunoblotting as described above.
3. Results
3.1. HOIL-1 and IRP2 can interact through the 73-aa domain in
HEK293 cells
Yamanaka et al. have suggested that a HOIL-1-dependent
mechanism is used for iron-mediated IRP2 degradation inHEK293
cells [17,19]. To determine if HOIL-1 has a role in IRP2
degradation, we first studied the interaction of HOIL-1 with IRP2
inHEK293 cells. FLAG-taggedHOIL-1 or an empty vector control
was transiently cotransfected into HEK293 cells with Myc-tagged
IRP2 or Myc-tagged IRP2 lacking the 73-aa domain (IRP2Δ73).
The coexpressed proteins were immunoprecipitated with either
FLAG or c-Myc antibodies, and the coimmunoprecipitation ofor COS-1 cells were cotransfected with IRP2-Myc (IRP2) and empty vector (EV) or
was replaced, and the cells were pretreatedwith 10μMMG132 for 30min prior to no
O (D) for 7.5 h (HEK293) or 3 h (COS-1) in the presence of MG132. (A and C)
g. 1A and B, respectively. ⁎ indicates non-specific bands.
Fig. 3. Transient expression of FLAG-HOIL-1 does not accelerate the degradation rate of IRP2-Myc. HEK293 cells were cotransfected with IRP2-Myc (IRP2) along with
either empty vector (EV) or FLAG-HOIL-1 (HOIL-1). (A) 30 μgwhole cell lysate was immunoblotted with c-Myc, FLAG, and actin antibodies to confirm appropriate protein
coexpression. (B) Transfected cells were pretreated for 30 min with met/cys-free medium and then labeled with 100 μCi/ml 35S-Met/Cys for 30 min. Cells were washed three
times and chased in complete medium (supplemented with 3% FBS) in the absence or presence of 100 μg/ml FAC for 0, 4, 8, 12, or 20 h. 35S-labeled IRP2-Myc was
immunoprecipitated using IRP2 antibody and analyzed by SDS-PAGE. (C)Quantificationwas performed to determine the half-life of 35S-labeled IRP2-Myc: 10.7±2.5 (n=2),
IRP2-Myc+EV (−FAC); 15.6±4.1 (n=3), IRP2-Myc+FLAG-HOIL-1 (−FAC); 8.9±6.1 (n=4) IRP2-Myc+EV (+FAC); 11.6±5.8 (n=3) IRP2-Myc+FLAG-HOIL-1
(+FAC). Half-lives are reported as the number of hours±the standard deviation with the number of experiments in parenthesis.
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immunoblotting. Immunoblotting was also performed on whole
cell lysates to confirm expression of the coexpressed constructs
(Fig. 1A). (We noted a slight reduction in IRP2-Myc and IRP2Δ73-
Myc protein with FLAG-HOIL-1 coexpression, this is due to a
reduction in mRNA levels resulting from the cotransfection of
multiple constructs (Supplementary Figs. 1 and 2)). Fig. 1B shows
that immunoprecipitation of FLAG-HOIL-1 results in the
coimmunoprecipitation of full-length IRP2-Myc but not
IRP2Δ73-Myc. Conversely, when IRP2-Myc or IRP2Δ73-Myc
is immunoprecipitated, FLAG-HOIL-1 coimmunoprecipitates only
with the full-length IRP2-Myc (Fig. 1C). These data show that
transiently overexpressed FLAG-HOIL-1 and IRP2-Myc interact
via the 73-aa domain in HEK293 cells.
3.2. Iron is not required for the interaction of HOIL-1 with IRP2
The interaction of HOIL-1 with IRP2 was shown to be iron-
dependent in COS-1 and RD4 cells [19]. To study the role of iron
in the interaction of HOIL-1with IRP2, we cotransfectedHEK293
as well as COS-1 cells with FLAG-HOIL-1 and either empty
vector control or IRP2-Myc, and treated the cells overnight with
the iron chelator desferrioxamine mesylate (DFO) to eliminate the
possibility of any iron-dependent interactions. The medium was
then removed, and the transfected cells were pretreated with theproteasome inhibitor MG132 for 30 min prior to the addition of
ferric ammonium citrate (FAC), hemin or DFO for an additional
7.5 h (HEK293) or 3 h (COS-1). Immunoblotting of whole cell
lysates was performed to confirm expression of the cotransfected
constructs (Fig. 2A and C), and the coimmunoprecipitation of
IRP2-Mycwith FLAG-HOIL-1 was assayed (Fig. 2B and D). Fig.
2B and D show that IRP2-Myc coimmunoprecipitates with
FLAG-HOIL-1 in control-, FAC- and hemin-treated HEK293 and
COS-1 cells. Surprisingly, IRP2-Myc also interacted with FLAG-
HOIL-1 in DFO-treated in HEK293 as well as COS-1 cells
(Fig. 2B andD). Our data show that the interaction of HOIL-1with
IRP2 is not iron-dependent inHEK293 cells, and unlikeYamanaka
et al. [19] we found that iron is also not required for the interaction
of HOIL-1 with IRP2 in COS-1 cells.
3.3. Overexpression of FLAG-HOIL-1 does not increase the
degradation rate of IRP2
It is important to note that although the steady-state levels of
transiently expressed IRP2were shown to be decreased inHEK293
cells withHOIL-1 coexpression byYamanaka et al. [19], the rate of
IRP2-degradation in the presence or absence of coexpressed
HOIL-1was not reported.We used pulse-chase analysis to quantify
the degradation rate of IRP2-Myc transiently coexpressed with
FLAG-HOIL-1 in HEK293 cells. Cotransfected cells were
Fig. 4. Stable expression of FLAG-HOIL-1 does not accelerate the degradation rate of endogenous IRP2. Control cells (Flp-In™ TREx™-293) or cells stably expressing
FLAG-HOIL-1 were induced overnight with 1 μg/ml tetracycline. (A) 30 μg whole cell extract was immunoblotted with IRP2, FLAG, and actin antibodies to observe the
steady-state levels of endogenous IRP2 (enIRP2), FLAG-HOIL-1, and actin, respectively. (B) Induced cells were pretreated for 30 min with met/cys-free medium and then
labeled with 100 μCi/ml 35S-Met/Cys for 1 h. Cells were washed three times and chased in complete medium (supplemented with 3% FBS) in the absence or presence of
100 μg/ml FAC (F) or 100 μM DFO (D) for 0, 3, or 6 h. 1 μg/ml tetracycline was present during the pretreatment, labeling, and chase. 35S-labeled endogenous IRP2 was
immunoprecipitated using IRP2 antibody and analyzed by SDS-PAGE. (C) Quantification was performed to determine the half-life of 35S-labeled endogenous IRP2: 10.3±3.2
(n=3), Control; 9.9±2.3 (n=2), FLAG-HOIL-1 Stable; 3.5±0.3 (n=3), Control (FAC); 3.6±0.3 (n=2), FLAG-HOIL-1 Stable (FAC). Half-lives are reported as the number of
hours±the standard deviation with the number of experiments in parenthesis.
250 K.B. Zumbrennen et al. / Biochimica et Biophysica Acta 1783 (2008) 246–252radiolabeled using 35S-Met/Cys for 30 min and then chased with
radiolabel-free medium supplemented with or without FAC for the
times indicated. Expression of all constructs was confirmed by
immunoblotting of unlabeled lysates (Fig. 3A). 35S-labeled whole-
cell lysates were immunoprecipitated with IRP2 antibody prior to
separation by SDS-PAGE. Fig. 3B and C show that while the
steady-state levels of IRP2-Myc are reduced with FLAG-HOIL-1
coexpression, the rate of IRP2-Myc degradation is not enhanced
with coexpression of FLAG-HOIL-1 in the presence or absence of
iron.
We also generated a stable HEK293 cell line that expresses
FLAG-HOIL-1 from a tetracycline-inducible promoter (Supple-
mentary Fig. 3) and used 35S-Met/Cys labeling to quantify the
degradation rate of endogenous IRP2 in the presence of FLAG-
HOIL-1. Control cells and cells stably expressing FLAG-HOIL-1
were induced with tetracycline overnight. Endogenous IRP2 was
labeled for 1 h, chased, and immunoprecipitated as described above.
Unlike the coexpression studies in which transient expression of
FLAG-HOIL-1 reduced the steady-state levels of transiently ex-
pressed IRP2-Myc, stable expression of FLAG-HOIL-1 does not
affect the steady-state levels of endogenous IRP2 (compare Fig. 4A
to Fig. 3A). Fig. 4B and C show that the degradation rate of 35S-
labeled endogenous IRP2 is not accelerated in the presence of
overexpressed FLAG-HOIL-1 with or without iron treatment.Taken together, these data indicate that HOIL-1 is not a limiting
factor for iron-mediated IRP2 degradation in HEK293 cells.
3.4. Overexpression of FLAG-HOIL-1 does not affect the
IRE-binding activity of endogenous IRP2
To determine if HOIL-1 overexpression alters IRP2 IRE-
binding activity, stable FLAG-HOIL-1 cells and untransfected
control cells were induced with tetracycline in the presence of
FAC or DFO and IRP2 RNA-binding activity was measured in
lysates by EMSA using a 32P-labeled ferritin-L IRE probe (Fig.
5A). We also measured the steady-state protein levels of IRE-
regulated ferritin in these lysates (Fig. 5B). These data show that
the overexpression of FLAG-HOIL-1 does not affect the IRE-
binding activity of IRP2 or alter the steady-state levels of ferritin.
3.5. Reduction of endogenous HOIL-1 by siRNA does not affect
the iron-dependent degradation of IRP2 in HEK293 cells
To determine if HOIL-1 is required for iron-mediated IRP2
degradation, we analyzed the regulation of endogenous IRP2 by
iron in HEK293 cells treated with HOIL-1 siRNA. HEK293 cells
were transfected with a pool of four HOIL-1-targeted siRNA
duplexes for 72 h, and then treated with FAC or DFO for 8 h.
Fig. 5. Stable expression of FLAG-HOIL-1 does not affect IRP2 IRE-binding.
Control cells (Flp-In™ TREx™-293) or cells stably expressing FLAG-HOIL-1
were induced overnight with 1 μg/ml tetracycline in the absence (C) or presence
of 100 μg/ml FAC (F) or 100 μM DFO (D). (A) In vitro IRE-binding activity
was assayed with 12 μg whole cell lysate using a 32P-labeled ferritin-L IRE
probe as described previously [24]. Indicated samples were treated with 0.5%
β-mercaptoethanol (β-ME) to activate latent IRP2 RNA-binding activity. All
samples were shifted using IRP2 antibody. (B) 12 μg whole cell lysate was immu-
noblotted sequentially with IRP2, FLAG, ferritin, and actin antibodies.
Fig. 6. Iron regulation of IRP2 is not altered with reduction of endogenous HOIL-1
by siRNA. HEK293 cells were untransfected or transfected with HOIL-1 siRNA for
24 h. Complete medium was added for an additional 48 h and then cells were
untreated (C) or treated with 100 μg/ml FAC (F) or 100 μM DFO (D) for 8 h.
Immunoblotting was performed using HOIL-1 monoclonal antibody (upper panel)
and IRP2 and actin antibodies (lower panel).
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down of steady-state protein levels of the two endogenousHOIL-1
isoforms (HOIL-1 and HOIL-1L [25]) in HEK293 cells (Fig. 6,
upper panel). Fig. 6 (lower panel) shows that siRNA knock-down
of both HOIL-1 isoforms has no effect on the iron-dependent
degradation or DFO-dependent stabilization of endogenous IRP2,
indicating that HOIL-1 is not required for iron-mediated IRP2
degradation in HEK293 cells.
4. Discussion
HOIL-1 was identified in a yeast two-hybrid screen and was
proposed to function as an E3-ubiquitin ligase that interacts with
the 73-aa domain of IRP2 to mediate iron-dependent IRP2
polyubiquitylation and proteasomal degradation in COS-1, RD4,
andHEK293 cells [19]. The role of HOIL-1 in IRP2 iron-mediated
degradation has remained controversial because of studies
showing that the 73-aa domain is not required for IRP2 iron-
degradation in HEK293 and H1299 cells [6,20,21]. Here, weprovide evidence that HOIL-1 does not have a role in the iron-
mediated degradation of IRP2 in HEK293 cells. First, we show
that transiently overexpressed IRP2 and HOIL-1 can interact in
HEK293 cells but that this interaction is not iron-dependent. In
contrast to Yamanaka et al. [19], we also observed that iron is not
required for the interaction of HOIL-1 with IRP2 in COS-1 cells.
Due to limited HOIL-1 antibody, we were not able to determine if
endogenous HOIL-1 and IRP2 can coimmunoprecipitate in
HEK293 or COS-1 cells. Second, using pulse-chase experiments
we show that transient or stable expression of HOIL-1 does not
accelerate the degradation rate of either transiently expressed IRP2
or endogenous IRP2, respectively, in HEK293 cells. While
Yamanaka et al. showed decreased steady-state levels of tran-
siently expressed IRP2 with HOIL-1 coexpression in HEK293
cells, they did not determine the actual rate of IRP2 degradation
with or without HOIL-1 coexpression [19]. Our studies from
HEK293 cells, which also show reduced IRP2 steady-state levels
with HOIL-1 coexpression, suggest that this may be a non-specific
consequence of the cotransfection of multiple constructs and not
due to increased protein turnover (Supplementary Figs. 1 and 2).
Third, we found that stable expression ofHOIL-1 in HEK293 cells
does not alter IRP2 IRE-binding activity or the expression of
ferritin. Finally, we demonstrate that reduction of endogenous
HOIL-1 protein in HEK293 cells by siRNA has no effect on the
iron-mediated degradation of IRP2. Taken together, our findings
indicate that HOIL-1 is not required for iron-mediated IRP2
degradation or for the regulation of IRP2 RNA-binding activity in
HEK293 cells. Although it is possible that HOIL-1mayhave a role
in IRP2 degradation in specific cells, such as RD4 cells [17,19],
this may be unlikely given that the 73-aa domain is dispensable for
IRP2 iron-dependent degradation in two other cell types [6,21].
We conclude that a HOIL-1-independent mechanism is likely
employed by most cell-types for iron-mediated IRP2 degradation.
If HOIL-1 is not involved in iron-mediated degradation of
IRP2, what is the physiological significance of the interaction of
HOIL-1 with the 73-aa domain of IRP2? Multiple yeast two-
252 K.B. Zumbrennen et al. / Biochimica et Biophysica Acta 1783 (2008) 246–252hybrid screens have shown that HOIL-1 can also interact with
diverse proteins including: hepatitis B virus-X protein [22], PKC
isoforms η, β1 and ζ [22,26], UbcM4 [27], and SOCS6 [28].
These studies have suggested alternative functions for HOIL-1 as a
transcriptional activator [26,29], an adaptor protein that facilitates
PKC-substrate phosphorylation [22], as well as a PKCβ1 shuttling
protein involved in the development of cardiac hypertrophy [30].
While our studies show that HOIL-1 is not involved in the iron-
mediated degradation of IRP2 or in the regulation of its RNA-
binding activity, a role for HOIL-1 in an as-yet-unidentified func-
tion of IRP2 cannot be completely excluded. Further efforts should
be focused on identifying the functional role of the interaction of
HOIL-1 with IRP2.
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